Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1
Inflammopharmacology · 2024
DOI: 10.1007/s10787-024-01448-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Kaiyuan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan,…. Hauptthemen laut MEDLINE: Inflammation, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Knockout. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis, a life-threatening condition characterized by dysregulated immune responses, remains a significant clinical challenge. Myricanol, a natural compound, plays a variety of roles in regulating lipid metabolism, anti-cancer, anti-neurodegeneration, and it could act as an Sirtuin 1 (SIRT1) activator. This study aimed to explore the therapeutic potential and underlying mechanism of myricanol in the lipopolysaccharide (LPS)-induced sepsis model. In vivo studies revealed that myricanol administration significantly improved the survival rate of LPS-treated mice, effectively mitigating LPS-induced inflammatory responses in lung tissue. Furthermore, in vitro studies demonstrated that myricanol treatment inhibited the expression of pro-inflammatory cytokines, attenuated signal pathway activation, and reduced oxidative stress in macrophages. In addition, we demonstrated that myricanol selectively enhances SIRT1 activation in LPS-stimulated macrophages, and all of the protective effect of myricanol were reversed through SIRT1 silencing. Remarkably, the beneficial effects of myricanol against LPS-induced sepsis were abolished in SIRT1 myeloid-specific knockout mice, underpinning the critical role of SIRT1 in mediating myricanol's therapeutic efficacy. In summary, this study provides significant evidence that myricanol acts as a potent SIRT1 activator, targeting inflammatory signal pathways and oxidative stress to suppress excessive inflammatory responses. Our findings highlight the potential of myricanol as a novel therapeutic agent for the treatment of LPS-induced sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, 430022, China.
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, 430022, China. pjthust@126.com.
- Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Wuhan, China. pjthust@126.com.
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. pjthust@126.com.
- Hubei Clinical Research Center for Metabolic and Cardiovascular Disease, Wuhan, China. pjthust@126.com.
Förderung
- the National Natural Science Foundation of China
Zitieren
APA
Liu, K., Yang, L., Wang, P., Zhu, J., Li, F., Peng, J., Huang, K., & Liang, M. (2024). Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01448-5
Vancouver
Liu K, Yang L, Wang P, Zhu J, Li F, Peng J, et al. Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01448-5
BibTeX
@article{Liu2024,
author = {Liu, Kaiyuan and Yang, Liuye and Wang, Pengchao and Zhu, Jingbo and Li, Fengcen and Peng, Jiangtong and Huang, Kai and Liang, Minglu},
title = {Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1},
journal = {Inflammopharmacology},
year = {2024},
doi = {10.1007/s10787-024-01448-5}
}
EUVIMED